Literature DB >> 18474581

Long-term suppression of hepatitis B virus replication by short hairpin RNA expression using the scaffold/matrix attachment region-based replicating vector system pEPI-1.

Andreas C W Jenke1, Andreas D Wilhelm, Valerie Orth, Hans Joachim Lipps, Ulrike Protzer, Stefan Wirth.   

Abstract

Since the emergence of viral resistance of hepatitis B virus (HBV) during treatment is becoming an important issue even with newer drugs, there is a need for alternative treatment options such as, for example, RNA interference (RNAi) technology. While short-term suppression of HBV replication is easily achieved with small interfering RNA oligonucleotides, this is not the case for long-term suppression due to the lack of an optimal vector system. Based on the nonviral scaffold/matrix attachment region (S/MAR)-based vector system pEPI-1, which is free of common side effects and is stably retained as an episome even in the absence of selection, we designed a short hairpin RNA (shRNA) expression vector called pEPI-RNAi for HBV suppression. HBV-replicating HepG2.2.15 cells were transfected with pEPI-RNAi, and the intracellular status of the plasmid was followed by PCR and Southern analysis. HBV replication was measured on the DNA, RNA, and protein level. HBV RNA expression was reduced by almost 85% 3 months posttransfection with pEPI-RNAi. At 8 months posttransfection in the absence of antibiotic selection pressure, the suppression level was still 70% and the vector was retained as an episome. The reduction of total intracellular HBV DNA at this point was 77%, showing a marked suppression of HBV DNA replication. At a comparable level, secretion of viral antigens, as well as progeny HBV virions, was inhibited. The S/MAR-based vector system pEPI-1 allows long-term suppression of HBV replication by the expression of suitable shRNAs. Due to its unique properties compared to commonly used vectors, it provides an interesting option for the treatment of chronically HBV-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474581      PMCID: PMC2443918          DOI: 10.1128/AAC.00067-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix.

Authors:  A Baiker; C Maercker; C Piechaczek; S B Schmidt; J Bode; C Benham; H J Lipps
Journal:  Nat Cell Biol       Date:  2000-03       Impact factor: 28.824

Review 2.  Approaches for the sequence-specific knockdown of mRNA.

Authors:  Lisa J Scherer; John J Rossi
Journal:  Nat Biotechnol       Date:  2003-12       Impact factor: 54.908

3.  An episomal mammalian replicon: sequence-independent binding of the origin recognition complex.

Authors:  Daniel Schaarschmidt; Jens Baltin; Isa M Stehle; Hans J Lipps; Rolf Knippers
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

4.  Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome.

Authors:  Andreas C W Jenke; Isa M Stehle; Frank Herrmann; Tobias Eisenberger; Armin Baiker; Jürgen Bode; Frank O Fackelmayer; Hans J Lipps
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-22       Impact factor: 11.205

5.  Inhibition of hepatitis B virus expression and replication by RNA interference.

Authors:  Amir Shlomai; Yosef Shaul
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

6.  Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation.

Authors:  Andreas C W Jenke; Monica F Scinteie; Isa M Stehle; Hans J Lipps
Journal:  Mol Biol Rep       Date:  2004-06       Impact factor: 2.316

7.  A concerted action of HNF4alpha and HNF1alpha links hepatitis B virus replication to hepatocyte differentiation.

Authors:  Maria Quasdorff; Marianna Hösel; Margarete Odenthal; Uta Zedler; Felix Bohne; Philippe Gripon; Hans-Peter Dienes; Uta Drebber; Dirk Stippel; Tobias Goeser; Ulrike Protzer
Journal:  Cell Microbiol       Date:  2008-03-11       Impact factor: 3.715

8.  Inhibition of hepatitis B virus in mice by RNA interference.

Authors:  Anton P McCaffrey; Hiroyuki Nakai; Kusum Pandey; Zan Huang; Felix H Salazar; Hui Xu; Stefan F Wieland; Patricia L Marion; Mark A Kay
Journal:  Nat Biotechnol       Date:  2003-05-12       Impact factor: 54.908

Review 9.  Chromosome-based vectors for gene therapy.

Authors:  H J Lipps; A C W Jenke; K Nehlsen; M F Scinteie; I M Stehle; J Bode
Journal:  Gene       Date:  2003-01-30       Impact factor: 3.688

10.  Exploiting a minimal system to study the epigenetic control of DNA replication: the interplay between transcription and replication.

Authors:  Isa M Stehle; Monica F Scinteie; Armin Baiker; Andreas C W Jenke; Hans J Lipps
Journal:  Chromosome Res       Date:  2003       Impact factor: 4.620

View more
  6 in total

Review 1.  Gene therapeutic approaches to inhibit hepatitis B virus replication.

Authors:  Maren Gebbing; Thorsten Bergmann; Eric Schulz; Anja Ehrhardt
Journal:  World J Hepatol       Date:  2015-02-27

2.  Restitution of gene expression and histone acetylation signatures altered by hepatitis B virus through antiviral microRNA-like molecules in nontransformed murine hepatocytes.

Authors:  Andreas Cw Jenke; Kai O Hensel; Andreas Klein; Lisa Willuhn; Susanna Prax; Patrick P Weil; Theodor Winkler; Timo Deba; Valerie Orth; Armin Baiker; Stefan Wirth; Jan Postberg
Journal:  Clin Epigenetics       Date:  2014-11-14       Impact factor: 6.551

Review 3.  A review on current status of antiviral siRNA.

Authors:  Abid Qureshi; Vaqar Gani Tantray; Altaf Rehman Kirmani; Abdul Ghani Ahangar
Journal:  Rev Med Virol       Date:  2018-04-15       Impact factor: 6.989

4.  Generation of a tumor- and tissue-specific episomal non-viral vector system.

Authors:  Rudolf Haase; Terese Magnusson; Baowei Su; Florian Kopp; Ernst Wagner; Hans Lipps; Armin Baiker; Manfred Ogris
Journal:  BMC Biotechnol       Date:  2013-06-04       Impact factor: 2.563

5.  Shortened nuclear matrix attachment regions are sufficient for replication and maintenance of episomes in mammalian cells.

Authors:  Xiao-Yin Wang; Xi Zhang; Tian-Yun Wang; Yan-Long Jia; Dan-Hua Xu; Dan-Dan Yi
Journal:  Mol Biol Cell       Date:  2019-09-11       Impact factor: 4.138

6.  Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy.

Authors:  Grace Elizabeth Mulia; Virginia Picanço-Castro; Eleana F Stavrou; Aglaia Athanassiadou; Marxa Leão Figueiredo
Journal:  Hum Gene Ther       Date:  2021-09-20       Impact factor: 5.695

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.